COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine
Transplant International · 2024
DOI: 10.3389/ti.2024.12729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, 2024. Verfasst von Letizia Corinna Morlacchi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Unit and Adult Cystic, Fibrosis Centre, Internal Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano…. Hauptthemen laut MEDLINE: Liver Transplantation, Lung Transplantation, BNT162 Vaccine, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
This study assessed humoral and T cell-mediated immune responses to the BNT162b2 vaccine in orthotopic liver transplant (OLT) and lung transplant (LUT) recipients who received three doses of the vaccine from March 2021 at our institution. Serum samples were collected 60 days post-second and third dose to quantify antibodies against the spike region of SARS-CoV-2 while whole blood samples were collected to analyze the SARS-CoV-2-specific T-cell response using an IFN-γ ELISpot assay. We enrolled 244 OLT and 120 LUT recipients. The third dose increased antibody titres in OLT recipients (from a median value of 131 after the second dose to 5523 IU/mL, p < 0.001) and LUT recipients (from 14.8 to 1729 IU/mL, p < 0.001). T-cell response also increased in OLT recipients (from 8.5 to 23 IFN-γ SFU per 250,000 PBMC, p < 0.001) and LUT recipients (from 8 to 15 IFN-γ SFU per 250,000 PBMC, p < 0.001). A total of 128 breakthrough infections were observed: two (0.8%) OLT recipients were hospitalized due to COVID-19 and one died (0.4%); among LUT recipients, seven were hospitalized (5.8%) and two patients died (1.7%). In conclusion, the three-dose schedule of the BNT162b2 vaccine elicited both humoral and T cell-mediated responses in solid organ transplant recipients. The risk of severe COVID-19 post-vaccination was low in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Respiratory Unit and Adult Cystic, Fibrosis Centre, Internal Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
- Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milano, Italy.
- Department of Pediatrics, Cystic Fibrosis Centre, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Division of Clinical Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
- Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
- General Surgery-Liver Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Förderung
- Ministero della Salute
Zitieren
APA
Morlacchi, L. C., Alicandro, G., Uceda Renteria, S., Zignani, N., Giacomel, G., Rossetti, V., Sagasta, M., Citterio, G., Lombardi, A., Dibenedetto, C., Antonelli, B., Rosso, L., Lampertico, P., Ceriotti, F., Blasi, F., & Donato, M. F. (2024). COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine. Transplant International. https://doi.org/10.3389/ti.2024.12729
Vancouver
Morlacchi LC, Alicandro G, Uceda Renteria S, Zignani N, Giacomel G, Rossetti V, et al. COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine. Transplant International. 2024. doi:10.3389/ti.2024.12729
BibTeX
@article{Morlacchi2024,
author = {Morlacchi, Letizia Corinna and Alicandro, Gianfranco and Uceda Renteria, Sara and Zignani, Nunzio and Giacomel, Giovanni and Rossetti, Valeria and Sagasta, Michele and Citterio, Gaia and Lombardi, Andrea and Dibenedetto, Clara and Antonelli, Barbara and Rosso, Lorenzo and Lampertico, Pietro and Ceriotti, Ferruccio and Blasi, Francesco and Donato, Maria Francesca},
title = {COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.12729}
}
EUVIMED